Invention Grant
- Patent Title: Method for inhibiting, improving, or preventing aging using recombinant fusion protein of pathogenic antigen protein and flagellin of Vibrio vulnificus
-
Application No.: US16197751Application Date: 2018-11-21
-
Publication No.: US11254714B2Publication Date: 2022-02-22
- Inventor: Kyung A. Cho , Jae Sung Lim , Joon Haeng Rhee
- Applicant: MEDISPAN CO., LTD.
- Applicant Address: KR Seongnam-si
- Assignee: MEDISPAN CO., LTD.
- Current Assignee: MEDISPAN CO., LTD.
- Current Assignee Address: KR Seongnam-si
- Agency: Clark & Elbing LLP
- Agent Susan M. Michaud
- Priority: KR10-2012-0138234 20121130
- Main IPC: C07K14/315
- IPC: C07K14/315 ; C07K14/28 ; A61K39/02 ; A61K39/09 ; A61K38/16 ; A61P31/04 ; C12N15/62 ; A61K39/00

Abstract:
The present invention relates to a method for inhibiting, improving, or preventing aging, comprising administering to a subject in need thereof a composition comprising a recombinant protein of flagellin, which is the constituent of Vibrio vulnificus flagella, fused with a pathogenic protein antigen, which is pneumococcal surface protein A (PsaA) of Streptococcus pneumonia. According to the present invention, the recombinant protein of the present invention can improve external and internal aging-related malfunctions and enhance immunity. Also, the composition of the present invention can easily perform immunization through mucosal administration.
Public/Granted literature
Information query